Syneron Medical, Ltd. engages in the design, development, and marketing of aesthetic medical products based on its proprietary Electro-Optical Synergy (ELOS) technology. Its ELOS technology combines optical energy, energy derived from light waves, with electrical energy, in particular radiofrequency energy, which results from the flow of electric charge through a conductor. The company’s products, which are sold primarily to physicians and other practitioners, target an array of noninvasive aesthetic medical procedures, including hair removal, wrinkle reduction, and rejuvenating the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions, as well as newer applications, including wrinkle reduction, and the treatment of acne and cellulite. Syneron Medical’s products platforms include Aurora, Pitanga, Polaris, Galaxy, Vela, and Comet. It sells its products through a direct sales force in North America; and a mix of direct sales personnel and distributors in Europe, the Middle East, Asia, Australia, New Zealand, and South America. As of March 31, 2004, the company had an installed base of approximately 1,400 products. Syneron Medical was incorporated in 2000 and is headquartered in Yokneam Illit, Israel.
Syneron Medical Ltd
PO Box 550
Yokneam Illit, 20692
Phone: 972 4 909 6200
Fax: 972 4 909 6202
Web Site: http://www.syneron.com
This is the iHub Message Board about Syneron Medical Ltd. (NasdaqNM: ELOS), where you can discuss the future prospects of the company and share information about it with others. This board is not connected in any way with the company, and any messages are solely the opinion and responsibility of the poster.